Ascensia fosters product innovation through new Ascensia Diabetes Challenge
LISBON, Portugal — Ascensia Diabetes Care on Wednesday announced the launch of the Ascensia Diabetes Challenge, a global innovation competition that is seeking innovative digital solutions to support diabetes management and improve the lives of those living with type 2 diabetes.
The challenge aims to find new ways to help tackle the management of the global epidemic of type 2 diabetes by unearthing undiscovered solutions from diabetes innovators. Finalists, runners-up and the winner will all receive cash prizes to support further development of their ideas from a total prize fund of almost $250,000.
"At Ascensia we are excited to be launching this challenge, as we want to encourage innovation in our field and rethink how digital technology can help people with type 2 diabetes manage their day to day lives," stated Michael Kloss, CEO Ascensia Diabetes Care. "This challenge represents the modern approach to finding innovative solutions for people with diabetes, alongside our own R&D," he said. "We hope this challenge can generate novel ideas from undiscovered sources, and with Ascensia's support we want to be able to bring them to a global patient population."
The competition will seek submissions from Europe, the Americas and Asia Pacific with entries open from Oct. 1, 2017 for Europe and Nov. 6, 2017 for Asia Pacific and the Americas. Entries can be submitted via the online portal at ascensiadiabeteschallenge.com.
Ascensia has partnered with yet2, an open innovation services company, to launch this global challenge. yet2 will be managing the submission process and initial review of entries.
"As a company that is focused on diabetes, we want to be driving the agenda in diabetes innovation, demonstrate our ongoing support for the diabetes community as a trusted partner, and show our commitment to continued research, innovation and development of new solutions," Kloss concluded.
HRG relocates nausea & motion sickness to digestive set for better traction
WAUKESHA, Wis.— Hamacher Resource Group on Tuesday announced the completion of its semiannual update to its taxonomy system for health, beauty and wellness, home health care and general merchandise products with notable adjustments to reflect industry changes.
The September 2017 Fine Lines updates include the move of motion sickness and vertigo products from Pain Relief to a new subcategory “nausea and motion sickness” in Digestive Health.
HRG’s team of analysts continually reviews the Fine Line classification system to determine whether modifications are necessary based on consumer market changes, emerging categories and subcategories or to reflect merchandising trends.
The team moved motion sickness and vertigo products to the Digestive Health category based on consumer and market behavior, and the trend of manufacturers of these products as well as retailers classifying them in the digestive department. These additions to Digestive Health expand the category by including more symptom treatments.
Strong repurchase rate story helps Good Clean Love expand retail distribution
EUGENE, Ore. — In a testament to the growth of organics in the personal care sector, intimacy products manufacturer Good Clean Love, a one-time Kroger exclusive, has expanded distribution through more than 10,000 doors this year, including Target, Safeway, Food Lions, CVS, Rite-Aid, Whole Foods, Walmart and Publix.
There are a number of feel-good factors associated with the brand. In addition to sourcing organic ingredients, Good Clean Love claims it is the first lubricant company to offer cruelty-free alternatives to animal testing, which recently earned the company the PETA Compassionate Business Award.
Those are both contributing factors to the 25% repurchase rate, the company noted, which Good Clean Love compares to the 1.5% repurchase rate of competitive personal lubricants.